The Chemistry and Biology of Resveratrol-based Oligomers
白藜芦醇低聚物的化学和生物学
基本信息
- 批准号:8440354
- 负责人:
- 金额:$ 30.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAddressAntifungal AgentsAntioxidantsAntiviral AgentsBehaviorBiochemicalBiologicalBiological FactorsBiologyBromineChemistryCollaborationsCollectionComplexDevelopmentDevicesEvaluationEventFamilyFuransHuman BiologyInvestigationLaboratoriesMalignant NeoplasmsMolecularMolecular ProbesNaturePathway interactionsPhenolsProcessPropertyReactionReagentRestResveratrolRoleScientistSeriesSocietiesSolutionsStructureSystemViralampelopsinanaloganti agingbaseimprovedinnovationlensoxidationprogramsred wineskillssmall moleculetumor
项目摘要
If scientists are to successfully address the largest biomedical challenges facing society,
our ability to both identify and create functional small molecules with unique properties must
improve dramatically. Natural products have long provided great starting points for such
investigations given that their structures have evolved over millennia to achieve specific
biochemical functions and their synthesis improves our skills. Yet, numerous classes of such
structures remain untapped. The most significant of these are oligomeric natural products,
compound families created in Nature from a simple building block through deliberately
uncontrolled reaction pathways that chemists have never been able to temper in the laboratory.
This proposal seeks to provide the innovative synthetic solutions needed to alter this paradigm
and finally access these classes of molecules in a controlled manner, thus enabling exploration
of their full biochemical potential.
Our initial proving ground lies with the resveratrol family of natural products, an abundant
class of compounds whose properties in initial screens appear perfect for a rich discovery
program given their structural uniqueness and anti-tumor, anti-viral, anti-fungal, anti-oxidant,
and anti-aging behavior (many by unknown or unique modes of action). Viewing these targets
through the lens of a unique synthetic strategy, we show how the diverse carbogenic complexity
of the entire class (along with several non-natural structures) can be assembled from a single,
common building block well removed from Nature's starting material through a series of creative
complexity-building sequences initiated by the simplest of reagents. These largely unexplored
compounds will then be screened thoroughly and deeply in concert with collaborators to
elucidate their roles in key biochemical events, especially as relates to human biology.
如果科学家要成功地解决社会面临的最大的生物医学挑战,
我们鉴定和创造具有独特性质的功能性小分子的能力必须
显著改善。长期以来,天然产品为这些产品提供了很好的起点。
研究,因为它们的结构已经发展了几千年,以实现特定的
生物化学功能及其合成提高了我们的技能。然而,许多这样的类
结构仍未开发。其中最重要的是低聚天然产物,
在自然界中创造的复合家庭,从一个简单的建筑块,通过故意
不受控制的反应途径,化学家们从来没有能够在实验室中调节。
该提案旨在提供改变这种范式所需的创新合成解决方案
并最终以可控的方式访问这些类别的分子,从而实现探索
它们全部的生化潜能。
我们最初的试验场在于白藜芦醇家族的天然产品,
一类化合物,其性质在初步筛选中似乎非常适合丰富的发现
计划鉴于其结构的独特性和抗肿瘤,抗病毒,抗真菌,抗氧化剂,
和抗衰老行为(许多未知或独特的作用模式)。查看这些目标
通过独特的合成策略的透镜,我们展示了不同的碳源复杂性
整个类别的(沿着几个非天然结构)可以由单个,
通过一系列创造性的方法,
由最简单的试剂引发的复杂构建序列。这些大部分未被探索的
然后,将与合作者一起对化合物进行彻底和深入的筛选,
阐明它们在关键生化事件中的作用,特别是与人类生物学有关的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott Alan Snyder其他文献
Scott Alan Snyder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott Alan Snyder', 18)}}的其他基金
Smooth Muscle Myosin PROTACs as a Novel Treatment for Asthma
平滑肌肌球蛋白 PROTAC 作为哮喘的新型治疗方法
- 批准号:
10592797 - 财政年份:2022
- 资助金额:
$ 30.45万 - 项目类别:
Utilizing Non-Functionalized Terpenes to Develop Novel Strategies and Chemoselective Transformations
利用非功能化萜烯开发新策略和化学选择性转化
- 批准号:
9903397 - 财政年份:2019
- 资助金额:
$ 30.45万 - 项目类别:
Utilizing Non-Functionalized Terpenes to Develop Novel Strategies and Chemoselective Transformations
利用非功能化萜烯开发新策略和化学选择性转化
- 批准号:
10397022 - 财政年份:2019
- 资助金额:
$ 30.45万 - 项目类别:
The Chemistry and Biology of Resveratrol-based Oligomers
白藜芦醇低聚物的化学和生物学
- 批准号:
7901189 - 财政年份:2009
- 资助金额:
$ 30.45万 - 项目类别:
The Chemistry and Biology of Resveratrol-based Oligomers
白藜芦醇低聚物的化学和生物学
- 批准号:
8232139 - 财政年份:2009
- 资助金额:
$ 30.45万 - 项目类别:
The Chemistry and Biology of Resveratrol-based Oligomers
白藜芦醇低聚物的化学和生物学
- 批准号:
8037629 - 财政年份:2009
- 资助金额:
$ 30.45万 - 项目类别:
The Chemistry and Biology of Resveratrol-based Oligomers
白藜芦醇低聚物的化学和生物学
- 批准号:
7786974 - 财政年份:2009
- 资助金额:
$ 30.45万 - 项目类别:
The Chemistry and Biology of Resveratrol-based Oligomers
白藜芦醇低聚物的化学和生物学
- 批准号:
8892314 - 财政年份:2009
- 资助金额:
$ 30.45万 - 项目类别:
Synthesis of the myrmicarin family of natural products
杨梅苷家族天然产物的合成
- 批准号:
6789741 - 财政年份:2004
- 资助金额:
$ 30.45万 - 项目类别:
Synthesis of the myrmicarin family of natural products
杨梅苷家族天然产物的合成
- 批准号:
6928463 - 财政年份:2004
- 资助金额:
$ 30.45万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 30.45万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 30.45万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 30.45万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 30.45万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 30.45万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 30.45万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 30.45万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 30.45万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 30.45万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 30.45万 - 项目类别:
Research Grant














{{item.name}}会员




